Michael A. Nazak's most recent trade in AN2 Therapeutics Inc was a trade of 16,600 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 15, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| AN2 Therapeutics Inc | Michael A. Nazak | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 16,600 | 16,600 | - | - | Stock Option (right to buy) |